berberine and lovastatin

berberine has been researched along with lovastatin in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (10.00)29.6817
2010's13 (65.00)24.3611
2020's5 (25.00)2.80

Authors

AuthorsStudies
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Sashidhara, KV; Singh, SP1
Golab, J; Issat, T; Jakóbisiak, M1
Berge, KE; Cameron, J; Kulseth, MA; Leren, TP; Ranheim, T1
Bil, J; Golab, J; Issat, T; Jakobisiak, M; Nowis, D; Winiarska, M1
Carlomagno, G; Fazio, S; Mercurio, V; Pirozzi, C; Ruvolo, A1
Borghi, C; Cicero, AF; Grandi, E; Morbini, M; Parini, A; Reggi, A; Rosticci, M1
Esposito, G; Izzo, R; Manzi, MV; Rozza, F; Santoro, M; Schiattarella, GG; Serino, F; Stabile, E; Trimarco, B; Trimarco, V1
Chen, Y; Feng, R; Fu, J; Gao, X; Guo, F; He, CY; Huang, M; Jiang, JD; Li, XY; Luo, SH; Ma, C; Ren, L; Shou, JW; Wang, Y; Wen, BY; Zhao, ZX1
Bisen, PS; Bundela, S; Sharma, A1
Cui, H; Dang, M; Dong, Y; Liu, H; Tong, X; Wang, J; Wu, J; Yang, F; Zhang, L; Zhang, Q1
Aquila, G; Calabria, D; Caliceti, C; Cicero, AFG; Ferrari, R; Fortini, F; Guardigli, M; Hrelia, S; Leoncini, E; Mirasoli, M; Rizzo, B; Rizzo, P; Roda, A; Simoni, P; Zambonin, L1
Di Pierro, F; Putignano, P; Villanova, N1
Feng, WW; Kuang, SY; Liu, TS; Ma, ZJ; Pang, JY; Tu, C; Wang, JB; Wang, YH; Xiao, XH; Zang, QC; Zhao, YL1
Battista, F; Bonaduce, D; Bosso, G; Brambilla, N; D'Amato, M; Fazio, V; Galletti, F; Gentile, M; Giacovelli, G; Mercurio, V; Pucci, G; Schillaci, G; Vitalini, C1
Carbone, F; Cremonini, AL; Di Pierro, F; Favari, E; Formisano, E; Pasta, A; Pisciotta, L; Ronca, A; Semino, T; Sukkar, SG1
Faggian, M; Marcheluzzo, S; Peron, G; Zancato, M1
Arnás, C; Corbella, E; de Dios, S; Florido, M; Licerán, M; Martin, D; Martinez-Martin, F; Petitbò, D; Pintó, X; Sánchez, A; Sánchez-Hernández, RM; Sarasa, I; Trias, F1
Ameneiros-Lago, E; Fernández-Fernández, FJ; Sardina-Ferreiro, R1
Laffin, LJ; Mirzai, S1

Reviews

2 review(s) available for berberine and lovastatin

ArticleYear
Lipid lowering agents of natural origin: An account of some promising chemotypes.
    European journal of medicinal chemistry, 2017, Nov-10, Volume: 140

    Topics: Animals; Biological Products; Dyslipidemias; Humans; Hypolipidemic Agents

2017
Supplements for Lipid Lowering: What Does the Evidence Show?
    Current cardiology reports, 2023, Volume: 25, Issue:8

    Topics: Animals; Berberine; Dietary Supplements; Humans; Lovastatin; Phytosterols

2023

Trials

6 trial(s) available for berberine and lovastatin

ArticleYear
Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2012, Volume: 22, Issue:5

    Topics: Anticholesteremic Agents; Berberine; Cardiotonic Agents; Dietary Supplements; Fatty Alcohols; Female; Humans; Insulin Resistance; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Vasodilation; Ventricular Remodeling

2012
Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia.
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2014, Volume: 21, Issue:3

    Topics: Adult; Anticholesteremic Agents; Berberine; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Dietary Supplements; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypercholesterolemia; Lipid Metabolism; Lovastatin; Norpregnenes; Pilot Projects; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Treatment Outcome

2014
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial.
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2015, Volume: 22, Issue:2

    Topics: Aged; Berberine; Biomarkers; Blood Glucose; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Dyslipidemias; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Insulin; Insulin Resistance; Italy; Lipids; Lovastatin; Male; Middle Aged; Morus; Plant Extracts; Plant Leaves; Time Factors; Treatment Outcome; Vasodilation

2015
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial.
    Lipids in health and disease, 2019, Mar-18, Volume: 18, Issue:1

    Topics: Adult; Aged; Berberine; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Fatty Alcohols; Female; Humans; Hypertrophy, Left Ventricular; Insulin Resistance; Lipid Metabolism; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Placebos; Treatment Outcome

2019
Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic Patients.
    Journal of medicinal food, 2020, Volume: 23, Issue:6

    Topics: Berberine; Dietary Supplements; Humans; Hypercholesterolemia; Lipids; Lovastatin; Proprotein Convertase 9; Silymarin

2020
Effects of treatment with monacolin K, berberine and coenzyme Q10 on lipid metabolism in patients with moderate cardiovascular risk.
    Semergen, 2022, Volume: 48, Issue:6

    Topics: Berberine; Cardiovascular Diseases; Cholesterol, LDL; Dietary Supplements; Heart Disease Risk Factors; Humans; Hypercholesterolemia; Lipid Metabolism; Lovastatin; Risk Factors; Treatment Outcome; Ubiquinone

2022

Other Studies

12 other study(ies) available for berberine and lovastatin

ArticleYear
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway.
    Oncology reports, 2006, Volume: 16, Issue:6

    Topics: Anticholesteremic Agents; Antineoplastic Agents; Berberine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; Lovastatin; Mevalonic Acid

2006
Berberine decreases PCSK9 expression in HepG2 cells.
    Atherosclerosis, 2008, Volume: 201, Issue:2

    Topics: Anticholesteremic Agents; Berberine; Cell Line; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Lovastatin; Plant Extracts; Proprotein Convertase 9; Proprotein Convertases; Receptors, LDL; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine Endopeptidases; Time Factors; Transcription, Genetic

2008
Antitumor effects of the combination of cholesterol reducing drugs.
    Oncology reports, 2011, Volume: 26, Issue:1

    Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; Berberine; Cell Cycle; Cell Line, Tumor; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mevalonic Acid; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms

2011
Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters.
    Journal of translational medicine, 2015, Aug-27, Volume: 13

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Berberine; Cholesterol; Cholesterol, LDL; Cricetinae; Diet, High-Fat; Dietary Fats; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; gamma-Glutamyltransferase; Hyperlipidemias; Lovastatin; Male; Mesocricetus; RNA, Messenger; Time Factors; Triglycerides

2015
Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Administration, Oral; Algorithms; Antineoplastic Agents; Berberine; Bortezomib; Colchicine; Databases, Pharmaceutical; Databases, Protein; Diterpenes; Humans; Hydroxamic Acids; Limonins; Lovastatin; Models, Statistical; Mouth Neoplasms; Predictive Value of Tests; Resveratrol; Rotenone; Stilbenes; Support Vector Machine; Vorinostat

2015
In Vivo and in Vitro Study on Drug-Drug Interaction of Lovastatin and Berberine from Pharmacokinetic and HepG2 Cell Metabolism Studies.
    Molecules (Basel, Switzerland), 2016, Apr-08, Volume: 21, Issue:4

    Topics: Animals; Berberine; Cytochrome P-450 CYP3A; Drug Interactions; Hep G2 Cells; Humans; Lovastatin; Rats

2016
Novel role of the nutraceutical bioactive compound berberine in lectin-like OxLDL receptor 1-mediated endothelial dysfunction in comparison to lovastatin.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2017, Volume: 27, Issue:6

    Topics: Anti-Inflammatory Agents; Antioxidants; Berberine; Cell Survival; Cells, Cultured; Cytoprotection; Extracellular Signal-Regulated MAP Kinases; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lovastatin; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; NF-kappa B; Nitric Oxide Synthase Type III; Oxidative Stress; Reactive Oxygen Species; Scavenger Receptors, Class E; Signal Transduction; Tumor Necrosis Factor-alpha

2017
Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in diabetic patients with dyslipidemia.
    Acta bio-medica : Atenei Parmensis, 2018, 01-16, Volume: 88, Issue:4

    Topics: Aged; Berberine; Biological Products; Diabetes Mellitus; Dietary Supplements; Dyslipidemias; Female; Glycated Hemoglobin; Humans; Lipids; Lovastatin; Male; Middle Aged; Retrospective Studies; Silymarin

2018
Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 99

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Berberine; Biological Products; Blood Glucose; Body Weight; Curcumin; Gene Expression Regulation; Inflammation; Insulin; Intra-Abdominal Fat; Lipid Metabolism; Lipids; Lipopolysaccharides; Liver; Lovastatin; Male; Non-alcoholic Fatty Liver Disease; Organ Size; Oxidative Stress; Rats, Sprague-Dawley

2018
Analysis of Monacolins and Berberine in Food Supplements for Lipid Control: An Overview of Products Sold on the Italian Market.
    Molecules (Basel, Switzerland), 2021, Apr-12, Volume: 26, Issue:8

    Topics: Berberine; Biological Products; Dietary Supplements; Italy; Lipids; Lovastatin

2021
[Nutraceuticals (monacolin K, berberine and coenzyme Q10) in patients with moderate hypercholesterolemia and low-moderate cardiovascular risk. Potential benefits of combined therapies].
    Semergen, 2023, Volume: 49, Issue:2

    Topics: Berberine; Cardiovascular Diseases; Dietary Supplements; Heart Disease Risk Factors; Humans; Hypercholesterolemia; Lovastatin; Risk Factors

2023